Delveinsight

NOVEMBER 29, 2020

Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market.

Marketing 52

Marketing Drug Delivery Pharma Companies Clinical Trials 52

pharmaphorum

AUGUST 10, 2020

While great progress has been made in diseases like diabetes, where HbA1c can be controlled for the majority of patients, we can still improve health outcomes further by providing better monitoring of disease and through more personalised drug delivery.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Delveinsight

FEBRUARY 14, 2021

The health regulatory agencies all over have issued several guidelines, released strategies, and amended regulations to expedite the drug delivery process in the rare disease market landscape.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry.

Scientist 52

Scientist In-Vitro Research Life Science 52

pharmaphorum

JUNE 10, 2021

If pharmaceutical companies’ steady price increases are wholly due to limitless greed or thirst for revenue growth, this certainly is not proven by the actual, factual financial results for these same companies. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

Roots Analysis

JANUARY 27, 2025

In order to help circumvent these disadvantages, several drug delivery devices, which enable patients to self-administer drugs through subcutaneous route are now being developed. This interest stems from their efficient and patient-friendly approach to administering medications.

Marketing 40

Marketing Drug Delivery Development Protein 40

pharmaphorum

JULY 9, 2021

Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for around £1 billion ($1.38 The UK pharma company says it has now withdrawn its recommendation to shareholders to accept that deal.

Drug Delivery 52

Drug Delivery Sales Production Drugs 52